Loading...
XNAS
MBOT
Market cap108mUSD
Dec 05, Last price  
2.37USD
1D
-3.66%
1Q
-35.25%
Jan 2017
-97.41%
Name

Microbot Medical Inc

Chart & Performance

D1W1MN
XNAS:MBOT chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
29.67%
Rev. gr., 5y
%
Revenues
0k
205,91492,85056,722231,730992,8701,426,9721,221,0001,367,9551,203,0001,012,000117,000000000000
Net income
-11m
L+6.55%
-11,738,350-18,948,380-25,022,802-29,086,777-27,026,411-25,243,551-21,328,000-28,491,153-26,439,000-32,741,000-36,415,000-9,663,000-7,589,000-7,240,000-7,350,000-9,249,000-11,269,000104,832,000-10,740,000-11,443,000
CFO
-9m
L+3.45%
-11,870,568-16,104,120-20,856,746-22,740,421-24,682,669-24,519,913-22,058,283-19,869,344-23,322,001-27,352,431-30,679,424-786,000-4,856,000-5,310,000-6,451,000-7,252,000-9,354,000-11,549,000-8,533,000-8,827,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
URL
http://www.microbotmedical.com/
IPO date
Mar 25, 1992
Employees
18
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT